X20 JSC
VN:X20
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8 900
12 100
|
Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
X20 JSC
Current Assets | 353.9B |
Cash & Short-Term Investments | 152.1B |
Receivables | 33.2B |
Other Current Assets | 168.6B |
Non-Current Assets | 196B |
Long-Term Investments | 3.5B |
PP&E | 169.8B |
Intangibles | 11.1B |
Other Non-Current Assets | 11.6B |
Current Liabilities | 285.2B |
Accounts Payable | 85.5B |
Accrued Liabilities | 55.8B |
Other Current Liabilities | 143.8B |
Non-Current Liabilities | 3.8B |
Other Non-Current Liabilities | 3.8B |
Balance Sheet
X20 JSC
Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash & Cash Equivalents |
145 436
|
23 844
|
75 506
|
35 147
|
26 915
|
57 714
|
126 863
|
111 060
|
55 569
|
|
Cash |
145 436
|
23 844
|
75 506
|
32 647
|
26 915
|
51 714
|
120 863
|
108 060
|
54 063
|
|
Cash Equivalents |
0
|
0
|
0
|
2 500
|
0
|
6 000
|
6 000
|
3 000
|
1 505
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5 122
|
300
|
|
Total Receivables |
210 966
|
166 594
|
240 469
|
338 497
|
69 921
|
39 053
|
41 236
|
55 576
|
103 202
|
|
Accounts Receivables |
202 707
|
147 031
|
229 754
|
328 185
|
47 088
|
23 665
|
31 905
|
49 335
|
89 508
|
|
Other Receivables |
8 259
|
19 563
|
10 715
|
10 312
|
22 833
|
15 388
|
9 331
|
6 241
|
13 694
|
|
Inventory |
231 130
|
234 191
|
269 201
|
300 889
|
164 445
|
194 204
|
205 623
|
171 508
|
219 540
|
|
Other Current Assets |
33 519
|
40 701
|
8 691
|
9 423
|
1 742
|
2 118
|
12 376
|
2 097
|
2 293
|
|
Total Current Assets |
621 050
|
465 330
|
593 867
|
683 956
|
263 023
|
293 089
|
386 099
|
345 362
|
380 903
|
|
PP&E Net |
172 870
|
210 639
|
245 869
|
251 140
|
248 050
|
223 135
|
202 783
|
180 603
|
184 745
|
|
PP&E Gross |
172 870
|
210 639
|
245 869
|
251 140
|
248 050
|
223 135
|
202 783
|
180 603
|
184 745
|
|
Accumulated Depreciation |
211 048
|
228 173
|
167 316
|
188 667
|
210 006
|
226 225
|
261 983
|
287 962
|
315 748
|
|
Intangible Assets |
2 182
|
5 487
|
5 495
|
5 353
|
5 391
|
5 313
|
11 705
|
11 429
|
11 223
|
|
Long-Term Investments |
1 659
|
1 659
|
1 659
|
1 659
|
1 659
|
2 916
|
3 256
|
3 444
|
3 348
|
|
Other Long-Term Assets |
12 664
|
8 483
|
5 377
|
3 809
|
10 044
|
4 035
|
1 950
|
11 600
|
9 545
|
|
Total Assets |
810 425
N/A
|
691 598
-15%
|
852 266
+23%
|
945 917
+11%
|
528 166
-44%
|
528 488
+0%
|
605 793
+15%
|
552 438
-9%
|
589 764
+7%
|
|
Liabilities | ||||||||||
Accounts Payable |
79 628
|
102 678
|
148 290
|
270 265
|
101 852
|
75 572
|
88 574
|
139 450
|
232 405
|
|
Accrued Liabilities |
45 280
|
44 035
|
38 796
|
56 966
|
47 433
|
60 374
|
59 439
|
69 074
|
74 069
|
|
Short-Term Debt |
0
|
0
|
0
|
128 168
|
84 207
|
21 095
|
4 150
|
0
|
0
|
|
Current Portion of Long-Term Debt |
300 000
|
191 310
|
242 964
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
123 906
|
92 634
|
161 110
|
233 793
|
46 073
|
115 436
|
185 157
|
84 118
|
20 619
|
|
Total Current Liabilities |
548 813
|
430 657
|
591 161
|
689 192
|
279 565
|
272 477
|
337 320
|
292 642
|
327 094
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
10 575
|
7 672
|
12 239
|
0
|
0
|
|
Other Liabilities |
500
|
500
|
998
|
998
|
998
|
998
|
998
|
3 249
|
3 464
|
|
Total Liabilities |
549 313
N/A
|
431 157
-22%
|
592 159
+37%
|
690 190
+17%
|
291 138
-58%
|
281 147
-3%
|
350 557
+25%
|
295 891
-16%
|
330 557
+12%
|
|
Equity | ||||||||||
Common Stock |
172 500
|
172 500
|
172 500
|
172 500
|
172 500
|
172 500
|
172 500
|
172 500
|
172 500
|
|
Retained Earnings |
37 342
|
32 949
|
30 972
|
26 263
|
7 530
|
17 843
|
24 564
|
20 046
|
18 615
|
|
Other Equity |
51 270
|
54 992
|
56 636
|
56 963
|
56 998
|
56 998
|
58 172
|
64 001
|
68 092
|
|
Total Equity |
261 112
N/A
|
260 441
0%
|
260 108
0%
|
255 726
-2%
|
237 028
-7%
|
247 341
+4%
|
255 236
+3%
|
256 547
+1%
|
259 207
+1%
|
|
Total Liabilities & Equity |
810 425
N/A
|
691 598
-15%
|
852 266
+23%
|
945 917
+11%
|
528 166
-44%
|
528 488
+0%
|
605 793
+15%
|
552 438
-9%
|
589 764
+7%
|
|
Shares Outstanding | ||||||||||
Common Shares Outstanding |
17
|
17
|
17
|
17
|
17
|
17
|
17
|
17
|
17
|